Screening for pulmonary hypertension in diastolic heart failure
Part of Heart & circulation, Lungs & breathing clinical trials.
This study screens people with diastolic heart failure (a type of heart failure where the heart pumps normally but is stiff) to see if they also have high blood pressure in the lungs, called pulmonary hypertension. It aims to better understand this condition and how it affects patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with diastolic heart failure, which means your heart's pumping is normal but it doesn't relax properly.
- Your doctor has used a special score (H2FPEF) to confirm this diagnosis.
- You may have symptoms like shortness of breath or fatigue that suggest high blood pressure in the lungs.
- You do not have heart failure with reduced pumping function (where the heart is weak and doesn't pump well).
- You do not have severe lung diseases like advanced COPD (a chronic lung condition) or severe scarring of the lungs.
- You do not have a type of blood clot in the lungs that causes high blood pressure (chronic thromboembolic pulmonary hypertension).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at pulmonary hypertension—high blood pressure in the lung arteries—in people with certain heart conditions (heart failure with preserved or reduced pumping function, or significant valve disease). It may help doctors better understand how lung blood pressure changes in these heart problems and guide care.
This trial uses data from standard heart tests to develop a better way to detect pulmonary hypertension, a condition of high blood pressure in the lungs. It aims to help doctors diagnose this condition earlier and more accurately.
This study is testing whether a new risk score can better predict outcomes for people who have both chronic lung disease and pulmonary hypertension (high blood pressure in the lungs). If you qualify, the researchers will follow your health over time to see how well the score works.
This study tests an investigational drug (HS235) for people who have both heart failure with preserved ejection fraction and a type of pulmonary hypertension that can happen with it. The goal is to see if the drug can improve symptoms and quality of life.
This study looks at whether a special CT scan of the lungs (CT pulmonary angiography) can give results similar to a more invasive heart catheterization test for measuring blood pressure in the lungs. It may help doctors diagnose and monitor pulmonary hypertension more easily in the future.
This study looks at how heart failure affects blood vessels in the lungs. If you have heart failure with reduced pumping ability and need a heart catheterization, you may be able to join.
Hear when a new Pulmonary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.